Global Uveitis Drugs Market Forecast to 2023; Led by AbbVie, Allergan, Johnson & Johnson Services, Novartis, and Pfizer – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Uveitis Drugs Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. Several risk factors associated with uveitis had been a challenge during the diagnosis of eye disorders. Considering the complexities related to the diagnosis, vendors in the market are developing novel diagnostic tools and methods to treat patients with uveitis. Several companies are introducing AI-implemented medical devices to detect the level of diabetic retinopat